Everolimus Safety in RCC Maintained With Expanded Access – Medscape
Everolimus Safety in RCC Maintained With Expanded AccessMedscapeFebruary 28, 2012 (Paris, France) — Under an expanded-access program, everolimus (Afinitor, Novartis) has a safety profile and tumor response consistent with those seen in RECORD-1 (Canc…